logo

BGLC

BioNexus Gene Lab·NASDAQ
--
--(--)
--
--(--)

BGLC fundamentals

BioNexus Gene Lab (BGLC) released its earnings on Nov 20, 2023: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Nov 20, 2023

Earnings

EPS
Revenue

Revenue & Expenses

BGLC has released its 2025 Q3 earnings report, with revenue of 2.54M, reflecting a YoY change of -3.29%, and net profit of -708.99K, showing a YoY change of 47.30%. The Sankey diagram below clearly presents BGLC's revenue sources and cost distribution.

Key Indicators

BioNexus Gene Lab (BGLC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

BioNexus Gene Lab (BGLC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

BioNexus Gene Lab (BGLC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

BioNexus Gene Lab (BGLC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does BioNexus Gene Lab (BGLC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track BioNexus Gene Lab (BGLC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield